Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel cancer therapies, today announced it will present updated data from CRDF-004, ...

Sandra Amis, an international development leader with more than 25 years of experience, was appointed as chief administrative officer of CRDF Global, a nonprofit organization that delivers security ...

Cardiff Oncology Inc. Annual stock financials by MarketWatch. View the latest CRDF financial statements, income statements and financial ratios.

Cardiff Oncology (CRDF) shares rallied 7% in the last trading session to close at $6.74. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Detailed price information for Legend Biotech Corp ADR (LEGN-Q) from The Globe and Mail including charting and trades.

Cardiff Oncology CRDF announced robust efficacy data from an ongoing mid-stage study evaluating two doses of its lead investigational candidate, onvansertib (20 mg and 30 mg), in combination with ...

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At ...

Ankur Rawat, an information technology industry executive, has joined CRDF Global as chief technology officer. He will oversee the digital strategy with a focus on advancing the nonprofit organization ...

Cardiff Oncology Inc. Annual cash flow by MarketWatch. View CRDF net cash flow, operating cash flow, operating expenses and cash dividends.